Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lucas' Papaw Ointment is a topical skin treatment and barrier cream that has been produced by the Australian company Lucas' Papaw Remedies since 1910. Originally formulated by Dr. Thomas Pennington Lucas, the ointment contains fermented Carica papaya (39 mg/g) in a base of pharmaceutical-grade petroleum jelly and a small amount of gum balsam Peru. It is utilized for its antibacterial and antimicrobial properties to treat a variety of minor skin ailments, including dry skin, chapped lips, minor wounds, grazes, sunburn, insect bites, and nappy rash. While it functions as a therapeutic agent, it is often categorized as a skincare product or therapeutic good rather than a conventional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lucas' Papaw Ointment.